Response to "Limitations of the Hazard Ratio as a Summary Measure in Cancer Clinical Trials". Zhao H, Li J, Zhang Z, Zhang L, et al. J Thorac Oncol 2021;16:e87-e88.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao H, Li J, Zhang Z, Zhang L, et al. Response to "Limitations of the Hazard Ratio as a Summary Measure in Cancer Clinical Trials". J Thorac Oncol 2021;16:e87-e88.
PMID: 34561044